A new furostan-type saponin (1) was isolated from the methanolic extract of Brunfelsia grandiflora leaves, together with four known compounds. The chemical structure of 1 was determined by spectroscopic analysis and chemical reaction to be 26
Brunfelsia grandiflora D. DON (Solanaceae), local name "chiricsanango", is widely cultivated in South America as an ornamental plant, and is also used in medicine. Its root is used against rheumatism and syphilis, and also has febrifuge activity. The leaf decoction is taken orally against arthritis and rheumatism in the Peruvian Amazon. 1) In the Amazon region, this plant is also used as an additive in the preparation of "ayahuasca". Although a few constituents of B. grandiflora have been reported, 2, 3) the chemical details of this plant have not yet been investigated thoroughly.
Leishmaniasis is endemic in tropical regions, and currently affects 12 million people in 88 countries. 4) This disease is transmitted by small biting sandflies (Phlebotomus sp.). The first-line drugs for the treatment of leishmaniasis are pentavalent antimonials such as N-methylglucamine antimonate (Glucantime) and sodium stilbogluconate (Pentostam). However, these drugs are toxic and generally expensive.
In a screening of South American medicinal plants for leishmanicidal activity, we found that B. grandiflora showed potent activity. In this report, we describe the chemical constituents of B. grandiflora and their leishmanicidal activities.
Results and Discussion
A new furostan-type saponin, 1, was isolated from the methanolic extract of B. grandiflora leaves, together with three known compounds: chlorogenic acid, scopoletin and 3- C-NMR data of 1-a were identical to those of neotigogenin, 5) which has a spirostanol structure.
Based on a comparison of the 13 C-NMR data of 1 and 1-a, the genuine aglycone was deduced to be furostanol-type because of large differences in the chemical shifts from C-22 to 27, and this was confirmed by 2D-NMR (DQFCOSY, HMQC, and HMBC). Furthermore, enzymatic hydrolysis by b-glucosidase (from almond) gave 1-b. Since 1-b lacked 1 mol of glucose compared with 1 in the 13 C-NMR spectrum (Table 1) , the latter molecule was surmised to possess a terminal glucose. A furostanol-type saponin bearing a sugar moiety at C-26 can release the sugar upon hydrolysis to form a spirostanol-type compound, and therefore a terminal glucose was determined to be located at C-26 by the correlation between C-26 (d C ϭ74.9 ppm) and HЈ-1 (d H ϭ4.82 ppm) in the HMBC spectrum. The anomeric configurations were deduced from the J values of the anomeric protons, and these values suggested the presence of four b-D-glucose units and one b-D-xylose unit. However, attempts to determine the glycosyl linkage of the sugar moiety at C-3 of 1 or 1-b based on the 2D-NMR spectra did not succeed because of hard overlapping signals in key correlations. To determine the glycosyl linkage, the method reported by Jansson et al. 6) was applied. Compound 1 was converted to a permethylated compound (1-c) by Hakomori's method. 7) Compound 1-c was subjected to acid hydrolysis and reduction with sodium borohydride followed by acetylation in situ, and the final reaction mixture was analyzed by GC-MS. In the GC-MS analysis, acetates of 2,3,4-trimethyl xylitol, 2,3,4,6-tetramethyl glucitol, 2,3,6-trimethyl glucitol, and 4,6-dimethyl glucitol were detected (see Experimental). Based on the results of GC-MS analysis, 1,4-disubstituted, 1,2,3-trisubstituted, and 1-monosubstituted glucoses and 1-monosubstituted xylose were deduced to be part of the sugar component of 1. Atmospheric pressure chemical ionization (APCI) and electrospray ionization (ESI) MS analysis of 1 and 1-b using product ion scan experiments with various collision energies were examined. The results revealed the presence of a terminal xylose (Xyl-) (M-132), a terminal glucose (Glc-) (M-162), an inner glucose combined with a glucose, and a xylose [(Glc)Xyl-Glc-] (M-456) and an inner glucose combined with two glucoses and a xylose [Xyl-(Glc)Glc-Glc] (M-618), however, a terminal diglucosyl fragment (Glc-Glc-) (M-324) was not found in 1-b. In addition, electron impact (EI)-MS analysis of acety- lated 1 showed no fragment 619, which was derived from a terminal diglucose heptaacetate [Glc(OAc) 4 -Glc(OAc) 3 -] . Based on this information, the glycosyl linkage position of 1-b was determined by 1D-HOHAHA technique and 2D-NMR (800 MHz) (Fig. 1) . The orientation of a methoxyl group at C-22 of 1 was determined to be a because the nuclear Overhauser effect (NOE) correlation between a methoxyl group and H-16 was observed. Thus the chemical structure of 1 was established as shown in Fig. 2 . To our knowledge, this compound has not been reported previously.
A New Leishmanicidal Saponin from Brunfelsia grandiflora
The IC 50 values of the leishmanicidal activities of 1 against L. major, L. guyanensis, and L. panamensis were 0.3, 5.5, and 8.0 mg/ml, respectively.
In conclusion, a new compound, 1, was isolated together with three known compounds. 1 was found to show leishmanicidal activity against L. major, L. guyanensis, and L. panamensis, and was especially potent against L. major. Compound 1 possesses a methoxyl group at C-22, which was thought to be inserted during extraction with methanol. C-NMR spectra were measured with a JEOL Alpha 500 spectrometer (500 MHz) and JEOL ECA 800 (800 MHz). IR spectra were recorded on a JASCO FTIR-5300 spectrometer. GC-MS and LC-MS were performed with a SHIMADZU QP 5050A and an Applied Biosystems QSTAR XL with an APCI, and ESI ion source apparatus, respectively. FAB-MS was measured by JEOL HX110 spectrometer. HPLC was run on Shimadzu LC-10VP system with JASCO OR-2090 Plus chiral detector.
Extraction and Isolation The methanolic extract of B. grandiflora leaves was prepared in Peru by Dr. Victor Zorrilla (Institute of Tropical Medicine, Lima, Peru). The concentrated extract (367 g) was dissolved in methanol and the solution was passed through a column of activated charcoal (70 g). Methanol (10 l), 30% chloroform/methanol (10 l), and chloroform were then each used as an eluent to give 3 Fractions (FR. A-B). Each fraction was concentrated in vacuo to give a syrup. The fraction eluted with methanol (FR. A) was subjected to column chromatography on silica gel (developing solvent: gradient with chloroform-methanol system) to afford 20 Fractions (FR. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Fractions eluted with 30-40% methanol/chloroform (FR. 7-9) were combined and evaporated under reduced pressure, and the residue was crystallized from methanol to give ursolic acid (670 mg). Fractions eluted with 60-70% methanol/chloroform (FR. 12-16) were combined and concentrated then partitioned between n-buthanol and water. The n-buthanol layer was concentrated in vacuo and the residue was chromatographed on Sephadex LH-20 with 80% methanol/water as an eluent to give 83 fractions (FR. 1Ј-83Ј). FR. 67Ј-83Ј were combined and concentrated to yield chlorogenic acid (565 mg). FR. 13Ј-33Ј were combined and rechromatographed on silica gel with a mixture of chloroformmethanol-water (100 : 20 : 1) as an eluent to afford 294 fractions (FR. 1Љ-294Љ). FR. 148Љ-177Љ were combined and the concentrated residue was subjected to HPLC (CapcelPak C-18, Shiseido, developing solvent: methanol/water (ϭ3 : 1-4 : 1)) to afford cirensenoside P (12 mg). FR. 208Љ-242Љ were combined and crystallized with methanol to yield 1 (1.08 g) as colorless fine needles. FR. B (eluted with 30% methanol/chloroform) was subjected to column chromatography on silica gel with a mixture of methanol and chloroform as an eluent then crystallized with chloroform-methanol to afford scopoletin (145 mg). Acid Hydrolysis of 1 Compound 1 (32 mg) was dissolved in 3% hydrochloric acid (12 ml) and the mixture was refluxed for 4 h. After cooling, the mixture was poured into ice water, and the precipitate was filtered to give neotigogenin (10 mg).
5) The filtrate was evaporated in vacuo, then a half residue was analyzed by HPLC with chiral detector [column: high-performance carbohydrate column (Waters), solvent system: 80% acetonitrile/water, flow rate: A solution of sodium hydride (60% oil suspended) (100 mg) in dimethyl sulfoxide (dried with molecular sieves 4A) (7.5 ml) was heated at 65°C with stirring for 60 min, and a solution of 1 (50 mg) in dimethyl sulfoxide (2.5 ml) was then added and the mixture was stirred for 1 h. Methyl iodide (0.75 ml) was added and the mixture was stirred at room temperature for 12 h. After the reaction, the mixture was poured into water and extracted twice with chloroform, and the organic layer was washed with water and evaporated in vacuo. The residue was subjected to preparative thin-layer chromatography (TLC) (development solvent system; chloroform/methanol (ϭ20 : 1)) to give a permethylated compound (1-c . 1-c was dissolved in 0.5 N-sulfuric acid in 90% acetic acid (10 ml), and the solution was stirred at room temperature for 30 min then at 77°C for 5 h. After being cooled, the reaction mixture was neutralized with silver carbonate and filtered. The filtrate was freeze-dried to give a residue. The residue was dissolved in water (5 ml) and sodium borohydride was added until halting foaming. The solution was stirred at room temperature for 2 h and then a few drops of acetic acid were added to stop the reaction. Methanol was added and the solution was concentrated under reduced pressure to afford a residue. Acetic anhydride (2 ml) and pyridine (2 ml) were added to the residue and the mixture was heated at 70°C for 2 h. After being cooled, water was added to the reaction mixture and the solution was stirred at room temperature for 30 min, extracted with chloroform, and evaporated in vacuo without heating to give a mixture of partially methylated alditol acetates. The mixture was analyzed by GC-MS. GC-MS analysis was performed with a DB-225 capillary column (I.D. 0.25 mmϫ30 m) (Agilent Technologies Co., Ltd.) at a column temperature of 170°C. The relative retention times and mass fragmentation patterns of detected peaks were compared with the values in the literature.
6) The following peaks were detected and their mass fragmentation patterns were identical to those reported previously: 4,6-dimethylglucitol acetate (retention time; 3.29 min), 2,3,6-trimethylglucitol acetate (2.09 min), 2,3,4,6-tetramethylglucitol acetate (1.0 min), and 2,3,4-trimethylxylitol acetate (0.61 min).
Leishmanicidal Activity Assay Cultivation of Leishmania promastigotes and leishmanicidal activity assay were carried out as we previously described. 9) Amphotericin B was used as a positive control (IC 50 0.04 mg/ml). The moderate leishmanicidal activities for ursolic acid, 10) chlorogenic acid, 11) and scopoletin 12) have been reported in the literature. Activity for cirensenoside P was not carried out due to amount shortage.
